Sign in

CIK 0001088856

  • Large accelerated filer

CORCEPT THERAPEUTICS INC

Sign in to watch
Ticker
CORT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
770487658
Phone
+1 650-688-8803
Business address
101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
  1. 4 Shares withheld for taxes Chief Business Officer gave up 256 shares (to pay taxes)
  2. 4 Open-market sale Chief Business Officer sold 2,326 shares at $71.27 ($165,774)
  3. 4 Planned sale Director sold 2,200 shares at $72.30 ($159,060)
  4. 4 Planned sale Chief Development Officer sold 35,007 shares at $71.77 ($2,512,452)
  5. 4 Planned sale Chief Development Officer sold 14 shares at $71.77 ($1,005)
  6. 4 Planned sale See Remarks sold 35,007 shares at an average $67.79 ($2,373,237)
  7. 4 Planned sale Chief Executive Officer sold 40,000 shares at an average $68.53 ($2,741,207)
  8. 4 Planned sale See Remarks sold 5,823 shares at $67.51 ($393,128)
  9. 4 Planned sale See Remarks sold 4,788 shares at an average $73.47 ($351,791)
  10. 4 Planned sale Chief Executive Officer sold 615 shares at $73.69 ($45,318)
  11. 4 Planned sale See Remarks sold 4,077 shares at an average $73.47 ($299,544)
  12. 4 Planned sale Chief Development Officer sold 4,879 shares at an average $73.48 ($358,495)
  13. 4 Planned sale Director sold 2,200 shares at $71.08 ($156,376)
  14. 4 Planned sale Chief Development Officer sold 100 shares at $73.51 ($7,351)
  15. 4 Planned sale See Remarks sold 100 shares at $73.51 ($7,351)
  16. 4 Planned sale See Remarks sold 205 shares at $73.45 ($15,058)
  17. 4 Open-market sale Chief Business Officer sold 3,185 shares at $70.77 ($225,402)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 7 of 60 · 1,196 filings